Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C275118-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $83.90 | |
C275118-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $249.90 | |
C275118-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $399.90 | |
C275118-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $799.90 | |
C275118-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,266.90 | |
C275118-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,999.90 |
Potent, selective μ opioid receptor antagonist
Synonyms | CTOP|CTOPA|103429-31-8|Ctop-NH2|Phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide|N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-phenylpropanoyl)amino]-10-(3-aminopropyl)-7-(1-hydroxyethyl)-16-[(4-hydroxyph |
---|---|
Specifications & Purity | ≥95% |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of μ receptor |
Product Description | CTOP TFA is a potent and highly selective μ-opioid receptor antagonist. CTOP TFA antagonizes the acute analgesic effect and hypermotility. CTOP TFA enhances extracellular dopamine levels in the nucleus accumbens. CTOP TFA dose-dependently enhances locomotor activity |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-phenylpropanoyl)amino]-10-(3-aminopropyl)-7-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide |
---|---|
INCHI | InChI=1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-38(58-43(66)33(52)21-28-11-6-5-7-12-28)47(70)56-36(22-29-16-18-31(64)19-17-29)45(68)57-37(23-30-24-54-34-14-9-8-13-32(30)34)46(69)55-35(15-10-20-51)44(67)60-40(27(2)63)48(71)61-41/h5-9,11-14,16-19,24,26-27,33,35-41,54,62-64H,10,15,20-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,68)(H,58,66)(H,59,72)(H,60,67)(H,61,71) |
InChi Key | PZWWYAHWHHNCHO-UHFFFAOYSA-N |
Canonical SMILES | CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O |
Isomeric SMILES | CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O |
PubChem CID | 2884 |
Molecular Weight | 1062.28(free base) |
PubChem CID | 5311058 |
---|---|
ChEMBL Ligand | CHEMBL507214 |
BindingDB Ligand | 50141040 |
CAS Registry No. | 103429-31-8 |
GPCRdb Ligand | CTOP |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2404378 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414348 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414349 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414350 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414351 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414352 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414353 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414359 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414360 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414377 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414379 | Certificate of Analysis | Feb 01, 2024 | C275118 |
C2414380 | Certificate of Analysis | Feb 01, 2024 | C275118 |
Solubility | Soluble in water |
---|
1. Wang Z et al.. (2021) Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition.. Brain, 144 (2): (665-681). [PMID:33367648] |